Phase I clinical trial of liposomal daunorubicin in hepatocellular carcinoma complicating liver cirrhosis

Anticancer Research

Volumn 20, Issue 2 B, 2000, Pages 1249-1251

  Daniele, Bruno ^a   De Vivo, Rocco ^a   Perrone, Francesco ^a   Lastoria, Secondo ^a   Tambaro, Rosa ^a   Izzo, Francesco ^a   Fiore, Francesco ^a   Vallone, Paolo ^a   Pignata, Sandro ^a,b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

DaunoXome ; Hepatocellular carcinoma; Phase I

Indexed keywords

DAUNORUBICIN; LIPOSOME;

ADULT; AGED; ARTICLE; BRAIN DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FORMULATION; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERBILIRUBINEMIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROTHROMBIN TIME;

AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; DAUNORUBICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG CARRIERS; FEMALE; HUMANS; HYPERBILIRUBINEMIA; LIPOSOMES; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTHROMBIN TIME;

EID: 0034010913     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. The Cancer of the Liver Italian Program (Clip) Investigators: A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28: 751-755, 1998.
2. CLIP Group (Cancer of the Liver Italian Programme): Tamoxifen in treatment of hepatocellular cercinoma: a randomised controlled trial. The Lancet 352: 17-20, 1498.
3. Colleoni M, Gaion F, Liessi G, Mastropasqua G, Nelli P, Manente P. Medical treatment of hepatocellular carcinoma: any progress? Tumori 80: 315-326, 1994.
4. Choi T, Lee N, Wong J: Chemotherapy for advanced hepatocellular carcinoma. Adriamycin vs quadruple chemotherapy. Cancer 53: 401-405, 1984.
5. Hoechster H, Green M, Speyer J, Fazzini E, Blum R, Muggia F: Epidoxorubicin: activity in hepatocellular carcinoma. J Clin Oncol 3: 1535-1540, 1985.
6. ® treatment of solid tumors: preclinical and clinical/investigation. J Liposome Res 4: 481-512, 1994.
7. Proffitt RT, Williams LE, Prcsant CA, Tin GW, et al. Tumor-imaging potential of liposomes loaded with In-111-NTA: biodistribution in mice. J Nucl Med 24: 45, 1983.
8. Williams LE, Proffitt RT, Lovisatti L: Possible applications of phospholipid vesicles (liposomes) in diagnostic radiology. J Nucl Med Allied Sci 28: 35, 1984.
9. Turner AF, Presant CA, Proffitt RT, Williams LE, Winsor DW, Werner JL: In-111-labeled liposomes: dosimetry and tumor depiction. Radiology 166: 761, 1988.
10. Williams LE, Duda RB, Proffitt RT, Beatty BG, Beatty JD, et al: Tumor uptake as a function of tumor mass: a mathematic model. J Nucl Med 29: 103, 1988.
11. Forssen EA, Coulter DM, Proffitt RT: Selective in vivo localization of Daunorubicin small unilamellar vescicles in solid tumors. Cancer Res 52: 3255-3261, 1992.
12. Guaglianone P, Chan K, DelaFlor-Weiss E, Hanisch R, Jeffers S, Sharma D, Muggia F: Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome). Invest New Drugs 12(2): 103-10, 1994.
13. Pugh RNH, Murray-Lyon IM, Dawson J-L, Pietroni MC, Williams R: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60: 646-649, 1973.
14. Miller AB, Hoogstraten B, Staquet M et al: Reporting results of cancer treatment. Cancer 47: 207-214, 1981.
15. Forseen EA, Malè-Brune R, Adler-Moore JP, Lee MSA, Schmidt PG, Krasieva TB et al. Fluorescence imaging studies for the disposition of Daunorubicin liposomes (DaunoXome) within tumor tissue. Cancer 56: 2066-2075, 1996.
16. Gill PS, Scadden DT, Cohen P et al. Randomized phase 111 trial of liposomal daunorubicin versus doxorubicin, bleomycin and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol 14: 2353-2364, 1996.
17. Steele JPC, O'Doherty CA, Evans M, Gover NH, Mulatero CW et al: Phase I/II trial of liposomal daunorubicin in malignant mesothelioma. Proc Am Soc Clin Oncol, A1933, 1998.
18. Isaksoon E, Wilking N, Molin C, Anderson E, Onetto N: Phase I trial of daunoxome and taxol as first line treatment in metastatic breast cancer. Pro Am Soc Clin Oncol A564, 1998.
19. Eckardt JR, Campbell E, Burris HA, Weiss GR et al: A phase II trial of DaunoXome, liposome encapsulated daunorubicin, in patients with metastatic adenocarcinoma of the colon. Am J Clin Oncol 17(6): 498-501, 1994.
20. ® in advanced urotelial transitional cell carcinoma. Eur J Cancer 34: 1131-1132, 1998.